What is the current Price Target for the SQZ Biotechnologies Co stock?

The average SQZ Biotechnologies Co target price is $44.88. This is 149,500.00% higher than the current stock price. The highest price target is 153,900.00%, the lowest is 148,033.33%. 3 Analysts have issued a price target SQZ Biotechnologies Co 2026 .

How high will the SQZ Biotechnologies Co stock rise?

No reliable answer can be given as to how high the SQZ Biotechnologies Co stock will rise. The performance of stocks, including the SQZ Biotechnologies Co stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the SQZ Biotechnologies Co stock today?

The performance of SQZ Biotechnologies Co stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the SQZ Biotechnologies Co stock fall?

The decline in SQZ Biotechnologies Co stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

SQZ Biotechnologies Co Forecast, price target & analysts

$0.03

30.43% day before yesterday

NYSE, Dec 03, 10:00 pm CET

ISIN

US78472W1045

Symbol

SQZB

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

SQZ Biotechnologies Co Target price 2025 - Analyst rating & recommendation

SQZ Biotechnologies Co Classifications & Recommendation:

Hold

50%

Sell

50%

SQZ Biotechnologies Co Price Target

Target Price	$44.88
Price	$0.03
Potential	149,500.00% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target SQZ Biotechnologies Co 2026 . The average SQZ Biotechnologies Co target price is $44.88. This is 149,500.00% register free of charge higher than the current stock price. The highest price target is $46.20 153,900.00% register free of charge , the lowest is $44.44 148,033.33% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend SQZ Biotechnologies Co to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the SQZ Biotechnologies Co stock has an average upside potential 2026 of 149,500.00% register free of charge . Most analysts recommend the SQZ Biotechnologies Co stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 & 2025

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '22	2023 Estimates
Earnings Per Share $	-2.76	-24.74
	10.84%	796.38%
P/E		0.00
EV/Sales		negative

Based on analysts' sales estimates for 2023, the SQZ Biotechnologies Co stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	-0.77	0.00%
2023	-45.69 5,833.29% Unlock

Current	0.07	9.12%
2023	4.31 5,809.18% Unlock

SQZ Biotechnologies Co...

Discover more stocks with a high price target

Netflix 1,273.57%

Coinbase Global, Inc. 48.88%

Adidas 48.28%

BioNTech SE - ADR 47.16%

Rheinmetall 45.71%

NIO ADR 42.52%

Deutsche Telekom 41.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now